Equities

Chemed Corp

Chemed Corp

Actions
Health CareHealth Care Providers
  • Price (USD)582.06
  • Today's Change-3.21 / -0.55%
  • Shares traded191.60k
  • 1 Year change+12.51%
  • Beta0.4427
Data delayed at least 15 minutes, as of Sep 20 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.

  • Revenue in USD (TTM)2.34bn
  • Net income in USD300.92m
  • Incorporated1970
  • Employees15.09k
  • Location
    Chemed Corp255 E. Fifth Street,, Suite 2600,CINCINNATI 45202United StatesUSA
  • Phone+1 (513) 762-6690
  • Fax+1 (302) 636-5454
  • Websitehttps://www.chemed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Select Medical Holdings Corp6.87bn258.77m4.55bn38.40k16.793.218.290.66212.082.0855.3110.890.8825--6.73178,985.004.304.195.345.4614.4213.984.875.11--3.960.678415.305.225.5753.0311.986.50--
Sotera Health Co1.10bn39.86m4.72bn3.00k118.9111.1623.674.300.14010.14013.881.490.35819.857.81366,062.001.31-0.8681.39-0.966455.1854.403.65-2.682.592.230.8459--4.547.06121.87--24.24--
Radnet Inc1.71bn9.92m5.13bn7.87k472.255.8229.452.990.14680.146824.5211.910.5775--8.14217,704.801.431.241.831.6622.8221.562.481.86--1.520.48440.0013.0510.64-71.42-37.6319.60--
CorVel Corp816.78m78.02m5.44bn4.87k70.4720.5951.956.664.504.5047.1315.411.81--8.98167,716.6017.2714.8730.2824.2121.7922.149.559.16----0.000.0010.685.9514.9010.5713.87--
Option Care Health Inc4.59bn211.31m5.46bn5.81k26.733.8719.951.191.191.1925.948.231.3813.2310.62790,263.806.343.637.974.3521.5522.454.602.781.367.040.44070.009.0643.4277.40--24.72--
R1 Rcm Inc2.38bn-40.00m5.98bn29.40k--2.1222.842.51-0.0956-0.09565.446.680.4393--5.8780,942.18-0.73841.35-0.79221.5320.4520.09-1.681.96--1.660.4453--24.7921.02105.21--25.07--
PACS Group Inc-100.00bn-100.00bn6.33bn32.43k--10.86----------3.75----------------------------0.4792--28.47---25.00------
Acadia Healthcare Company Inc3.06bn-5.12m7.10bn23.50k--2.3748.932.32-0.0725-0.072533.3732.210.5647--8.32179,836.800.07052.320.07922.64----0.12495.601.175.440.3754--12.208.99-107.93--3.34--
Ensign Group Inc3.97bn225.40m8.62bn35.30k38.655.1928.372.173.903.9068.7529.050.9458--7.99112,397.305.396.456.437.8821.3622.325.696.48--354.480.08156.5623.2716.28-6.8028.624.405.02
Chemed Corp2.34bn300.92m8.76bn15.09k29.527.2324.113.7519.7219.72153.0180.511.44133.4215.30154,805.9018.5719.5322.4924.6435.9634.6012.8812.601.73--0.008.156.064.909.175.801.466.10
Encompass Health Corp5.07bn409.00m9.32bn22.36k23.085.0711.501.844.013.8949.7818.280.8279--9.04226,825.008.656.3711.017.9495.4995.5810.459.16--5.900.517830.7810.412.3441.314.4916.60-10.42
Solventum Corp8.21bn1.06bn12.08bn22.01k11.414.217.491.476.136.1347.5016.600.58173.977.36372,926.807.50--8.72--56.98--12.89--0.958410.030.7434--0.8241--0.2234------
Data as of Sep 20 2024. Currency figures normalised to Chemed Corp's reporting currency: US Dollar USD

Institutional shareholders

42.67%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20241.67m11.07%
BlackRock Fund Advisorsas of 30 Jun 20241.26m8.40%
Kayne Anderson Rudnick Investment Management LLCas of 30 Jun 2024580.32k3.86%
Durable Capital Partners LPas of 30 Jun 2024550.20k3.66%
Neuberger Berman Investment Advisers LLCas of 30 Jun 2024502.62k3.34%
William Blair Investment Management LLCas of 30 Jun 2024477.85k3.18%
SSgA Funds Management, Inc.as of 30 Jun 2024460.79k3.06%
Geode Capital Management LLCas of 30 Jun 2024319.65k2.12%
Impax Asset Management Ltd.as of 30 Jun 2024317.94k2.11%
TD Asset Management, Inc.as of 30 Jun 2024282.75k1.88%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.